Cite
APA Citation
Yamanishi, K., Ellis, B., Kudo, K., Kayanoki, T., Dews, I., Ostor, A., & Wilson, A. (2013). tHU0223 The Novel CPLA2 Inhibitor AK106-001616 is a New Category of Anti-Inflammatory/Analgesic Drug Demonstrating Efficacy and Favorable Tolerability in the Treatment of Rheumatoid Arthritis. Annals of the rheumatic diseases, 72, A240. http://access.bl.uk/ark:/81055/vdc_100137787035.0x00005c